Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,375.30
    +1,062.54 (+2.11%)
     
  • CMC Crypto 200

    1,367.54
    +54.92 (+4.18%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Stocks - Tesla, BAT, Newmont Rise in Premarket; Incyte Falls

Investing.com -- Stocks in focus in premarket trade on Thursday, 3rd January.

Tesla (NASDAQ:TSLA) stock rose 1.7% after the company reported it shipped a record 112,000 vehicles in the three months through December, 6,000 more than Wall Street forecasts. As such, it delivered roughly 367,500 cars last year, a 50% increase from 2018.

Incyte (NASDAQ:INCY) stock fell 10.4% after the biopharma company said after the bell on Thursday that its itacitinib drug had failed a late-stage clinical trial. The drug was intended for use in combination with corticosteroids to treat patients whose bodies reject transplanted bone marrow or stem cells.

Newmont Goldcorp (NYSE:NEM) stock rose 1.8%, shadowing the rally in the precious metal after a U.S. airstrike killed an Iranian general, triggering a flight to haven assets in markets worldwide.

ADVERTISEMENT

Oil producers broadly rose in reaction to the spike in crude prices after the U.S. airstrike. Devon Energy (NYSE:DVN) rose 3.0%, Occidental Petroleum (NYSE:OXY) rose 2.7%, ConocoPhillips (NYSE:COP) rose 1.6% and Exxon Mobil (NYSE:XOM) rose 1.0%. Chevron (NYSE:CVX) rose 0.7%.

Arista Networks (NYSE:ANET) fell 1.4% after it announced the departure of its chief customer officer late on Thursday.

British American Tobacco (LON:BATS) ADRs rose 2.2% after the company said it will file applications for regulatory approval of all its vaping products by the FDA’s May 12 deadline.

Related Articles

Police body camera maker Axon sues U.S. Federal Trade Commission amid antitrust probe

UK tobacco shares rise on U.S. e-cigarette ban exemptions

Futures slump after U.S. kills top Iranian commander